Worth Financial Advisory Group LLC Sells 604 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Worth Financial Advisory Group LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 45.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 736 shares of the healthcare conglomerate’s stock after selling 604 shares during the quarter. Worth Financial Advisory Group LLC’s holdings in UnitedHealth Group were worth $375,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Hall Capital Management Co. Inc. boosted its position in shares of UnitedHealth Group by 6.3% in the second quarter. Hall Capital Management Co. Inc. now owns 5,343 shares of the healthcare conglomerate’s stock worth $2,721,000 after purchasing an additional 318 shares during the period. Harbour Investments Inc. increased its stake in UnitedHealth Group by 1.4% in the 2nd quarter. Harbour Investments Inc. now owns 6,336 shares of the healthcare conglomerate’s stock worth $3,226,000 after buying an additional 89 shares in the last quarter. Patriot Financial Group Insurance Agency LLC lifted its position in shares of UnitedHealth Group by 7.9% in the second quarter. Patriot Financial Group Insurance Agency LLC now owns 3,497 shares of the healthcare conglomerate’s stock valued at $1,781,000 after acquiring an additional 256 shares in the last quarter. AustralianSuper Pty Ltd grew its position in shares of UnitedHealth Group by 13.8% during the second quarter. AustralianSuper Pty Ltd now owns 432,828 shares of the healthcare conglomerate’s stock worth $220,422,000 after purchasing an additional 52,484 shares in the last quarter. Finally, Atomi Financial Group Inc. lifted its holdings in UnitedHealth Group by 19.5% in the 2nd quarter. Atomi Financial Group Inc. now owns 7,046 shares of the healthcare conglomerate’s stock worth $3,588,000 after purchasing an additional 1,148 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Robert W. Baird boosted their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Barclays increased their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday, August 21st. Royal Bank of Canada lifted their price objective on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Finally, JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. One research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Trading Up 0.0 %

UNH stock traded up $0.22 during midday trading on Tuesday, reaching $587.35. The company’s stock had a trading volume of 1,581,941 shares, compared to its average volume of 4,136,158. The firm has a market capitalization of $542.37 billion, a price-to-earnings ratio of 35.90, a PEG ratio of 1.61 and a beta of 0.59. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $592.34. The stock has a fifty day simple moving average of $539.79 and a two-hundred day simple moving average of $510.36. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter last year, the firm earned $6.14 EPS. The business’s quarterly revenue was up 6.4% on a year-over-year basis. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.43%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.